SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-004539
Filing Date
2024-01-08
Accepted
2024-01-08 17:11:00
Documents
13
Period of Report
2024-01-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d689996d8k.htm   iXBRL 8-K 33853
2 EX-3.1 d689996dex31.htm EX-3.1 128697
  Complete submission text file 0001193125-24-004539.txt   321781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcab-20240105.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20240105_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20240105_pre.xml EX-101.PRE 11257
7 EXTRACTED XBRL INSTANCE DOCUMENT d689996d8k_htm.xml XML 3426
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 24521006
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)